[go: up one dir, main page]

WO2012036518A3 - Novel antibiotically active compound and an antibiotic composition comprising the compound - Google Patents

Novel antibiotically active compound and an antibiotic composition comprising the compound Download PDF

Info

Publication number
WO2012036518A3
WO2012036518A3 PCT/KR2011/006879 KR2011006879W WO2012036518A3 WO 2012036518 A3 WO2012036518 A3 WO 2012036518A3 KR 2011006879 W KR2011006879 W KR 2011006879W WO 2012036518 A3 WO2012036518 A3 WO 2012036518A3
Authority
WO
WIPO (PCT)
Prior art keywords
compound
antibiotic composition
antibiotically active
active compound
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2011/006879
Other languages
French (fr)
Korean (ko)
Other versions
WO2012036518A2 (en
Inventor
강린우
김정구
안예진
이병무
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University Industry Cooperation Corporation of Konkuk University
Korea Rural Development Administration
Original Assignee
University Industry Cooperation Corporation of Konkuk University
Korea Rural Development Administration
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Industry Cooperation Corporation of Konkuk University, Korea Rural Development Administration filed Critical University Industry Cooperation Corporation of Konkuk University
Publication of WO2012036518A2 publication Critical patent/WO2012036518A2/en
Publication of WO2012036518A3 publication Critical patent/WO2012036518A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to a novel antibiotically active compound and to an antibiotic composition comprising the compound, and more specifically relates to a compound that inhibits bacterial cell growth and to a use for the compound.
PCT/KR2011/006879 2010-09-17 2011-09-16 Novel antibiotically active compound and an antibiotic composition comprising the compound Ceased WO2012036518A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100092037A KR101156666B1 (en) 2010-09-17 2010-09-17 Novel compound and Antibiotic Composition comprising the same
KR10-2010-0092037 2010-09-17

Publications (2)

Publication Number Publication Date
WO2012036518A2 WO2012036518A2 (en) 2012-03-22
WO2012036518A3 true WO2012036518A3 (en) 2012-06-07

Family

ID=45832134

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/006879 Ceased WO2012036518A2 (en) 2010-09-17 2011-09-16 Novel antibiotically active compound and an antibiotic composition comprising the compound

Country Status (2)

Country Link
KR (1) KR101156666B1 (en)
WO (1) WO2012036518A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5418218A (en) * 1992-07-10 1995-05-23 The University Of Maryland At Baltimore Histidyl-proline diketopiperazine (cyclo his-pro) a cns-active pharmacologic agent
US20030225103A1 (en) * 2000-08-04 2003-12-04 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
US20050119177A1 (en) * 2003-05-15 2005-06-02 David Bar-Or Treatment of T-cell mediated diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002010156A1 (en) 2000-07-29 2002-02-07 Arpida Ag Benzofuran derivatives and their use as antibacterial agents
KR20080041722A (en) * 2005-08-31 2008-05-13 와이어쓰 9-aminocarbonyl substituted derivatives of glycylcycline

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5418218A (en) * 1992-07-10 1995-05-23 The University Of Maryland At Baltimore Histidyl-proline diketopiperazine (cyclo his-pro) a cns-active pharmacologic agent
US20030225103A1 (en) * 2000-08-04 2003-12-04 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
US20050119177A1 (en) * 2003-05-15 2005-06-02 David Bar-Or Treatment of T-cell mediated diseases

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
EVANS ET AL.: "Metabolic effects of platelet-activating factor in rats in vivo: Stimulation of hepatic glycogenolysis and lipogenesis", BIOCHEM. J., vol. 269, no. 1, 1 July 1990 (1990-07-01), pages 269 - 272 *
GOUNTOPOULOU ET AL.: "TNF is a potent inducer of platelet-activating factor synthesis in adipocytes but not in preadipocytes: Differential regulation by PI3K", CYTOKINE, vol. 41, no. 2, 3 January 2008 (2008-01-03), pages 174 - 181, XP022458537, DOI: doi:10.1016/j.cyto.2007.11.008 *
HANSEL ET AL.: "Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity", J CLIN ENDOCRINOL METAB, vol. 89, no. 10, 1 October 2004 (2004-10-01), pages 4963 - 4971 *
IYER ET AL.: "Inflammatory lipid mediators in adipocyte function and obesity", NATURE REVIEWS ENDOCRINOLOGY, vol. 6, 1 February 2010 (2010-02-01), pages 71 - 82, XP055212341, DOI: doi:10.1038/nrendo.2009.264 *
YANG ET AL.: "Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis", GUT, vol. 53, no. 6, 1 January 2004 (2004-01-01), pages 877 - 883 *

Also Published As

Publication number Publication date
KR101156666B1 (en) 2012-06-15
WO2012036518A2 (en) 2012-03-22
KR20120029908A (en) 2012-03-27

Similar Documents

Publication Publication Date Title
KR20180085042A (en) Bismuth-thiols as antiseptics for agricultural, industrial and other uses
NZ613076A (en) A composition comprising an antibiotic and a dispersant or an anti -adhesive agent
MX342913B (en) Romidepsin solid forms and uses thereof.
WO2013184755A3 (en) Seca inhibitors and methods of making and using thereof
MY162411A (en) Crystalline forms of a macrolide, and uses therefor
NZ622566A (en) Chromobacterium bioactive compositions and metabolites
NZ618571A (en) Peptides and their use
WO2011088027A8 (en) Compounds and methods
AU2011278165A8 (en) Adhesive composition including deacetylated chitosan
MX2011008043A (en) Actagardine derivatives.
WO2013052683A3 (en) Antibacterial metallic nanofoam and related methods
WO2012148720A3 (en) Anti-microbial peptides and methods of use thereof
WO2011119954A3 (en) Antimicrobial silica composites
WO2012036523A3 (en) Novel antibiotically active compound and an antibiotic composition comprising the compound
WO2010056914A8 (en) Bacterial helicase inhibitor compounds and uses thereof
WO2012036520A3 (en) Novel antibiotically active compound and an antibiotic composition comprising the compound
WO2012036518A3 (en) Novel antibiotically active compound and an antibiotic composition comprising the compound
WO2012015269A3 (en) Phosphaphenanthrene-carbazole-based organic light-emitting compound, and organic light-emitting device comprising same
WO2011006097A3 (en) Methods For Treating Toxicity
PH12011000384A1 (en) Pesticidal composition and method for controlling pests
WO2013098413A3 (en) Composition that inhibits bacterial growth and use thereof
HK1182925A (en) Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
AU2010900721A0 (en) Insecticidal composition
AU2010901173A0 (en) Enhanced Plant Growth Enhanced with Specific Agent
HK1184739A (en) Romidepsin solid forms and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11825478

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11825478

Country of ref document: EP

Kind code of ref document: A2